Elevance Health, Inc.

LSE:0HG8 Stock Report

Market Cap: US$93.4b

Elevance Health Future Growth

Future criteria checks 2/6

Elevance Health is forecast to grow earnings and revenue by 12.7% and 6.7% per annum respectively. EPS is expected to grow by 15.8% per annum. Return on equity is forecast to be 17.6% in 3 years.

Key information

12.7%

Earnings growth rate

15.8%

EPS growth rate

Healthcare earnings growth23.3%
Revenue growth rate6.7%
Future return on equity17.6%
Analyst coverage

Good

Last updated18 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

LSE:0HG8 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026200,3558,7858,7929,16412
12/31/2025187,2897,5307,5798,04915
12/31/2024175,1116,3435,0325,44312
9/30/2024174,0156,4188712,131N/A
6/30/2024171,7196,6918202,067N/A
3/31/2024171,7456,2442,2963,570N/A
12/31/2023171,3405,9876,7658,061N/A
9/30/2023168,6265,9968,2469,514N/A
6/30/2023165,7166,31010,57111,825N/A
3/31/2023160,6766,09411,12812,327N/A
12/31/2022156,5995,8947,2478,399N/A
9/30/2022153,2516,16610,39511,589N/A
6/30/2022149,1346,0728,0229,169N/A
3/31/2022144,3536,2287,2638,400N/A
12/31/2021138,6436,1587,2778,364N/A
9/30/2021133,8835,5189,48010,505N/A
6/30/2021129,2194,2315,7786,851N/A
3/31/2021124,6324,7149,65710,678N/A
12/31/2020121,8684,5729,66710,688N/A
9/30/2020117,4494,9557,1088,202N/A
6/30/2020112,9655,9169,96011,019N/A
3/31/2020109,1674,7795,8996,946N/A
12/31/2019104,2124,8074,9846,061N/A
9/30/2019100,1654,2984,1515,197N/A
6/30/201996,7424,0743,0074,137N/A
3/31/201994,2203,9892,0183,242N/A
12/31/201892,0913,7502,6193,827N/A
9/30/201891,4094,5568912,063N/A
6/30/201890,5844,344N/A3,861N/A
3/31/201890,0614,145N/A3,712N/A
12/31/201790,0493,843N/A4,185N/A
9/30/201789,0552,980N/A5,763N/A
6/30/201788,0382,851N/A4,322N/A
3/31/201787,0832,777N/A4,599N/A
12/31/201684,8622,470N/A3,270N/A
9/30/201683,3642,282N/A3,943N/A
6/30/201681,8662,319N/A3,322N/A
3/31/201680,4122,398N/A3,825N/A
12/31/201579,1582,560N/A4,212N/A
9/30/201577,9592,886N/A3,472N/A
6/30/201576,6052,862N/A3,734N/A
3/31/201575,0662,734N/A3,632N/A
12/31/201473,8862,560N/A3,369N/A
9/30/201472,7922,362N/A3,337N/A
6/30/201472,0902,385N/A4,129N/A
3/31/201471,3072,453N/A3,483N/A
12/31/201371,0242,634N/A3,052N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 0HG8's forecast earnings growth (12.7% per year) is above the savings rate (2.1%).

Earnings vs Market: 0HG8's earnings (12.7% per year) are forecast to grow slower than the UK market (14.6% per year).

High Growth Earnings: 0HG8's earnings are forecast to grow, but not significantly.

Revenue vs Market: 0HG8's revenue (6.7% per year) is forecast to grow faster than the UK market (3.5% per year).

High Growth Revenue: 0HG8's revenue (6.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 0HG8's Return on Equity is forecast to be low in 3 years time (17.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y